Degradable Implant Market Trends and Forecast
The future of the global degradable implant market looks promising with opportunities in the orthopedic, cardiovascular, dental, and neurosurgery markets. The global degradable implant market is expected to grow with a CAGR of 6.8% from 2025 to 2031. The major drivers for this market are the increase in orthopedic procedures, the rising demand for biocompatible materials, and the growing adoption of minimally invasive surgeries.
• Lucintel forecasts that, within the type category, absorbable metal is expected to witness the highest growth over the forecast period.
• Within the application category, orthopedic is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Degradable Implant Market
The degradable implant market is changing swiftly, fueled by technological innovation, rising patient demand for minimally invasive procedures, and regulation. The following are five emerging trends that are transforming the market:
• Technological Developments in Biomaterials: One of the most important trends is the creation of new biomaterials that are tougher, more elastic, and degradable. Scientists are working to enhance the mechanical properties of degradable implants while making them safely degrade over time. Advances in polymers, ceramics, and metals are allowing for the development of implants that more closely resemble natural tissue, providing improved performance and a lower risk of complications. These advances are broadening the scope of applications for degradable implants, especially in orthopedics, cardiovascular therapies, and dental implants.
• Compatibility with 3D Printing Technology: 3D printing is transforming the manufacture of degradable implants through highly customized and patient-specific implants. This technology supports the precise fabrication of implants designed to the patientÄX%$%Xs specific anatomy, enhancing the fit and function of the implants. With advancing 3D printing methods, the market is expected to experience increased usage of personalized medical solutions, lowering surgical complications and enhancing patient outcomes. Furthermore, 3D printing allows the testing of new biodegradable materials that better fit particular medical uses.
• Expansion into Drug Delivery Systems: Implants that break down are increasingly being utilized to deliver drugs under controlled conditions. This is particularly common in pain management and oncology, where implants can be engineered to deliver drugs slowly and directly to the targeted area, with targeted delivery. This decreases the requirement for oral medications and reduces side effects, providing patients with a more efficient and targeted therapeutic treatment. As developmental research on biodegradable drug delivery systems progresses, their use is likely to extend to other areas of medicine, heightening the range and demand for degradable implants.
• Emphasis on Sustainability and Green Solutions: The increased focus on sustainability in healthcare is fueling the creation of degradable implants using green, biodegradable materials. Companies are seeking alternatives to traditional plastic-based materials by creating polymers that disintegrate naturally, minimizing environmental footprint. The trend follows worldwide efforts to decrease medical waste and enhance the sustainability of healthcare procedures. With growing demand for environmentally friendly solutions, degradable implants become an increasingly viable choice for both patients and healthcare practitioners.
• Expanded Use in Elderly and Pediatric Patients: Degradable implants are increasingly being used in the treatment of elderly and pediatric patients, who have special medical requirements. In elderly patients, the decreased requirement for implant removal surgeries makes degradable implants a perfect choice. For pediatric patients, the fact that they can utilize implants that break down over time eliminates the requirement for further surgeries as they age. With the aging of the global population and the growing number of pediatric surgeries, the need for degradable implants specific to these populations is likely to increase substantially.
These new trends are transforming the degradable implant market through enhanced functionality, personalization, and sustainability of implants. Innovations in biomaterials, 3D printing, and drug delivery systems are broadening applications, while sustainability and increased use in special populations are providing greater accessibility and appeal to healthcare providers. As these trends persist, the degradable implant market is poised for dramatic expansion.
Recent Development in the Degradable Implant Market
The degradable implant market is transforming at a fast rate, with some major developments stimulating its growth. They involve advances in materials, manufacturing techniques, and regulatory approval, all stimulating the growth of the market.
• Creation of Bioresorbable Stents: One of the biggest advancements in the degradable implant market is the development of bioresorbable stents. These stents support blood vessels temporarily and then dissolve slowly, eliminating the necessity for a follow-up procedure to have the stent removed. Their mechanical strength and degradation rate have been enhanced by recent advancements, rendering them a potential substitute for conventional metallic stents. With additional clinical trials proving their efficacy and safety, bioresorbable stents are likely to become an accepted treatment in cardiovascular medicine.
• Advances in Orthopedic Implants: In orthopedics, the degradable implants are being used to support bone regeneration by gradually dissolving over time. This does not require further surgeries to take out the implants. Recent advancements in materials such as poly(lactic acid) (PLA) and poly(glycolic acid) (PGA) have enhanced the mechanical properties of these implants to the extent that they can be used in weight-bearing applications. These developments are likely to minimize the occurrence of complications like infection and implant rejection, further fueling the use of degradable orthopedic implants.
• New Device Regulatory Approvals: Regulatory authorities such as the FDA and EMA have, in recent times, cleared some new degradable implant devices to pave the way for wider usage. Such approvals have included the bioresorbable stent, orthopedic implants, and dental implants, all showing promising results through clinical trials. With the ongoing changes in the regulatory landscape, it is plausible that further degradable implant devices will gain approval, continuing to spur market expansion and widening the accessibility of patients to such novel treatments.
• Enhanced Drug-Eluting Implants: Drug-eluting degradable implants are meant to release drugs during the course of time, and they are targeted for the therapy of conditions such as cancer and chronic pain. Research in this field has centered on enhancing the mechanisms of release and the fact that the drug delivery should be effective and controlled. Incorporating drug-eluting characteristics into degradable implants is widening their applications in therapy, hence making them a viable choice in oncology and other medical fields.
• Partnerships and Collaborations in Research and Development: Heightened cooperation among universities, medical device companies, and healthcare professionals has fueled the degradable implant industryÄX%$%Xs innovation process. Such partnerships have resulted in advancements in biomaterials and production methods, which have compelled the creation of more efficient and cost-effective degradable implants. With an increase in stakeholders engaging to solve challenges in the industry, the formulation of new and better degradable implants is bound to persist.
These are the critical advancements that are making the future of the degradable implant market better by enhancing the effectiveness, accessibility, and variety of devices available. Due to advancements in materials, drug delivery, and approval by regulatory bodies, the market has the potential for sustained growth, giving improved choices to patients and healthcare practitioners.
Strategic Growth Opportunities in the Degradable Implant Market
The market for degradable implants offers many growth opportunities in various medical uses. These are driven by materials science progress, rising patient interest in non-surgical treatments, and expanding attention to sustainability in medicine.
• Orthopedic Uses: Orthopedic degradable implants, especially in bone repair and joint replacement, hold high growth potential. The implants are particularly desirable for patients who would otherwise need multiple procedures to remove the implant. With advances in technology, the number of orthopedic conditions treated using degradable implants is likely to increase, giving a cost-saving and environmentally friendly option compared to conventional permanent implants.
• Cardiovascular Applications: Degradable implants, including bioresorbable stents, are revolutionizing cardiovascular medicine. They provide the advantage of stabilizing blood vessels for additional time and then breaking down those stents, minimizing the need for a follow-up procedure. As the technology becomes more advanced and clinical evidence demonstrating its effectiveness develops, usage of degradable cardiovascular implants will expand.
• Dental Applications: In dentistry, degradable implants are applied to bone regeneration as well as dental implants that progressively dissolve in a period of time. The application is set to increase with patients looking for substitute dental implants which may have to be removed or replaced later on. The advancements in the growth of degradable materials to serve oral care as well as regeneration of tissue is fueling development in this market.
• Drug Delivery Systems: Degradable implants for drug delivery systems are emerging in oncology, pain relief, and other therapeutic applications. Such implants have the ability to dispense controlled amounts of drug over time, providing localized and targeted action while reducing side effects. With advancing technology, future opportunities for degradable drug-eluting implants will increase.
• Neurovascular Applications: In neurovascular surgery, biodegradable implants hold the promise of aiding tissue regeneration without the necessity of permanent foreign bodies. These implants are particularly useful in the treatment of brain or spinal cord trauma, as they offer temporary support during the healing process. As research continues, the neurovascular segment will become an important growth area for biodegradable implants.
Such strategic growth prospects are fueling degradable implant market growth by delivering innovative solutions within various areas of medicine. Due to growing need for sustainable and minimally invasive procedures, the applications will reshape the future direction of the degradable implant market.
Degradable Implant Market Driver and Challenges
The market for degradable implants is driven by several technological, economic, and regulatory factors. Drivers are pushing the market growth forward, while challenges remain in some areas.
The factors responsible for driving the degradable implant market include:
1. Technological Developments: Ongoing developments in biomaterials, manufacturing techniques, and implant design are making it possible to create more efficient and safer degradable implants. These advances are enhancing the performance of degradable implants, increasing their clinical utility, and minimizing the requirement for invasive procedures.
2. Increasing Demand for Minimally Invasive Therapies: Minimally invasive therapies are sought more and more by patients and physicians to minimize the risk of complications and ensure faster healing. Degradable implants can meet this demand with effective therapies and fewer subsequent procedures, leading their application in a number of medical specialties.
3. Regulatory Support: Supportive regulatory conditions, especially in established economies such as the U.S. and Europe, have enabled regulatory clearance for degradable implants. With additional devices cleared for regulation, the market will continue to grow, and medical professionals will have greater confidence in these implantsÄX%$%X safety and effectiveness.
4. Aging Population: With the aging population worldwide, there is a growing demand for medical devices that minimize the requirement for follow-up operations or the removal of implants. Biodegradable implants that break down over time are increasingly becoming a popular choice for older patients, especially in orthopedic and cardiovascular procedures.
5. Emphasis on Sustainability: The increasing focus on environmental sustainability is escalating the need for bio-based degradable implants. The healthcare industry, as well as manufacturers, is more interested than ever before in minimizing medical waste, and degradable implants provide a green solution to this problem.
Challenges in the degradable implant market are:
1. High Production Costs: The expense of production and development of degradable implants continues to be a major obstacle. As technology improves, costs are decreasing step by step, but the initial cost of these implants is still greater than conventional ones, restricting their use in some markets.
2. Long-Term Performance and Reliability: Long-term performance and reliability issues regarding the long-term performance and reliability of degradable implants, particularly in weight-bearing situations, remain an impediment. Maintaining their mechanical strength levels and controlled rates of degradation are critical for the general acceptance of these implants.
3. Regulatory Barriers: Getting through the maze of regulations may slow the introduction of new degradable implants into the market. Strict approval procedures in some markets may hinder the speed of innovation and restrict the supply of new technologies.
Technological innovation, demand for minimally invasive procedures, and regulatory incentives are chief drivers of the degradable implant industry. But high costs of manufacturing, long-term performance issues, and regulatory issues must be resolved to ensure greater acceptability. The degradable implant market is expected to experience high growth with a wide range of opportunities in diverse medical applications.
List of Degradable Implant Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies degradable implant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the degradable implant companies profiled in this report include-
• Abbott Vascular
• 3M
• Royal DSM
• Boston Scientific
• Kyoto Medical Planning
• Bakony Technical
• Superior Technical Ceramics
• Lifetech Scientific Corporation
• SINOMED
• Elixir
Degradable Implant Market by Segment
The study includes a forecast for the global degradable implant market by type, application, and region.
Degradable Implant Market by Type [Value from 2019 to 2031]:
• Medical Composite Materials
• Polymer Materials
• Absorbable Metals
• Absorbable Ceramics
• Others
Degradable Implant Market by Application [Value from 2019 to 2031]:
• Orthopedics
• Cardiovascular
• Dental
• Neurosurgery
• Others
Degradable Implant Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Degradable Implant Market
Degradable implants, that slowly disintegrate and get absorbed by the body over time, have emerged as a pioneering approach to a variety of medical uses, from orthopedic to cardiology to dental treatment. These implants are being made with the intention of minimizing surgical removal and enhancing patient outcomes through the removal of long-term issues from conventional permanent implants. Recent advancements in the United States, China, Germany, India, and Japan are indicative of major improvements in materials, manufacturing processes, and regulatory approvals, improving the marketÄX%$%Xs growth opportunities. Following is the overview of the advancements in each country.
• United States: The United States leads the degradable implant market, with innovations aimed at enhancing the mechanical properties and degradation rates of biodegradable materials. Some of the recent advancements consist of the approval of new biodegradable implants in areas such as orthopedics and cardiovascular medicine. Firms are investing in biodegradable polymer technology so that the implants degrade at predetermined levels, reducing the need for secondary surgery. The FDAÄX%$%Xs encouraging regulatory environment has driven innovation and approval rates. Nevertheless, high manufacturing costs and the difficulty in obtaining long-term implant durability continue to be top challenges that require more attention in the market.
• China: China has been booming in the degradable implant market with active government promotion of medical device innovation. Research and development of biodegradable materials are concentrated on enhancing their performance in bone regeneration, cardiovascular devices, and tissue engineering. The nation is making progress in the production of bioresorbable stents and orthopedic implants. Furthermore, ChinaÄX%$%Xs rising healthcare expenditure and increasing healthcare infrastructure add to a rising demand for such implants. Nonetheless, product quality concerns and regulatory issues in the local market could hinder further widespread use in certain markets.
• Germany: Germany is a pioneer of the European degradable implant market, backed by robust research in biomaterials and medical device manufacturing. Some of the major developments are bioresorbable stents and high-tech orthopedic implants that slowly disintegrate in the body. GermanyÄX%$%Xs high-quality standards for medical devices and regulatory system promote innovation and protect patient safety. In addition, the growing emphasis on sustainable healthcare solutions due to environmental and economic pressures has propelled the use of degradable implants. Cost considerations and the necessity for additional clinical data on the long-term performance of these implants are still issues.
• India: IndiaÄX%$%Xs degradable implant market is expanding as the nationÄX%$%Xs healthcare infrastructure develops and patients demand more sophisticated medical interventions. Technological advancements in biodegradable materials are being used in orthopedic procedures, dental implants, and drug delivery systems. Government policies favoring medical research and the growing need for affordable healthcare solutions are propelling the market. The cost-effectiveness of degradable implants, particularly in comparison to conventional implants, makes them a popular choice in the Indian healthcare system. But there are challenges in the form of regulatory barriers, unawareness, and fewer experts trained to use sophisticated implant technologies.
• Japan: Japan is experiencing uniform growth in the degradable implant industry, especially in cardiovascular devices and orthopedic implants. Biodegradable materials like polylactic acid (PLA) and polyglycolic acid (PGA) are being researched, and it is allowing the creation of implants that offer a safer, minimally invasive option compared to permanent implants. JapanÄX%$%Xs demographic aging and intense need for high-tech healthcare solutions drive market growth. Cost factors and regulatory difficulties for new implants can, nonetheless, hinder broader adoption. Further research and trials will be necessary to overcome such obstacles and continue fueling market growth.
Features of the Global Degradable Implant Market
Market Size Estimates: Degradable implant market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Degradable implant market size by type, application, and region in terms of value ($B).
Regional Analysis: Degradable implant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the degradable implant market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the degradable implant market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for degradable implant market?
Answer: The global degradable implant market is expected to grow with a CAGR of 6.8% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the degradable implant market?
Answer: The major drivers for this market are the increase in orthopedic procedures, the rising demand for biocompatible materials, and the growing adoption of minimally invasive surgeries.
Q3. What are the major segments for degradable implant market?
Answer: The future of the degradable implant market looks promising with opportunities in the orthopedic, cardiovascular, dental, and neurosurgery markets.
Q4. Who are the key degradable implant market companies?
Answer: Some of the key degradable implant companies are as follows:
• Abbott Vascular
• 3M
• Royal DSM
• Boston Scientific
• Kyoto Medical Planning
• Bakony Technical
• Superior Technical Ceramics
• Lifetech Scientific Corporation
• SINOMED
• Elixir
Q5. Which degradable implant market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, absorbable metal is expected to witness the highest growth over the forecast period.
Q6. In degradable implant market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the degradable implant market by type (medical composite materials, polymer materials, absorbable metals, absorbable ceramics, and others), application (orthopedics, cardiovascular, dental, neurosurgery, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Degradable Implant Market, Degradable Implant Market Size, Degradable Implant Market Growth, Degradable Implant Market Analysis, Degradable Implant Market Report, Degradable Implant Market Share, Degradable Implant Market Trends, Degradable Implant Market Forecast, Degradable Implant Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.